logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11377503 B1

PDFFull Text
Date of Patent:
Jul. 05, 2022

Filed:

Jun. 17, 2019

Antibodies that bind human cd39 and inhibit atpase activity of a soluble extracellular domain human cd39 polypeptide

Applicant:

Innate Pharma, Marseilles, FR;

Inventors:

Stéphanie Chanteux, Marseilles, FR;

Laurent Gauthier, Marseilles, FR;

Nicolas Gourdin, Marseilles, FR;

Carine Paturel, Marcy l'Etoile, FR;

Ivan Perrot, Cassis, FR;

Benjamin Rossi, Marseilles, FR;

Assignee:

INNATE PHARMA, Marseilles, FR;

Attorney:

Knobbe, Martens, Olson & Bear, LLP

Primary Examiner:

Robert S Landsman

Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61P 35/00 (2018.01); G01N 33/57492 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/41 (2013.01); C07K 2317/52 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/74 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

The present invention relates to antigen-binding compounds that inhibit the enzymatic activity of soluble human CD39. The invention also relates to cells producing such compounds; methods of making such compounds, and antibodies, fragments, variants, and derivatives thereof; pharmaceutical compositions comprising the same; methods of using the compounds to diagnose, treat or prevent diseases, e.g., cancer.

Find Patent Forward Citations

Quick Actions:

Chanteux, Stéphanie. (2022). Antibodies that bind human cd39 and inhibit atpase activity of a soluble extracellular domain human cd39 polypeptide (U.S. Patent No. 11377503). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11377503

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…